文献速递帕金森病与运动障碍

术前快速眼动睡眠行为障碍与帕金森病丘脑底核脑深部电刺激术后1年结局

Preoperative REM Sleep Behavior Disorder and Subthalamic Nucleus Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery.
PubMed 文献 · Neurology · 2021-10-19

本研究基于法国多中心前瞻性PREDISTIM研究,分析448例帕金森病患者的术前临床特征,其中215例完成术后12个月随访。比较术前很可能快速眼动睡眠行为障碍(RBD)阳性与阴性患者,发现两组在运动、认知、精神行为及生活质量结局上无显著差异,提示术前很可能RBD不影响术后1年临床结局。

要点

  • 术前很可能RBD阳性与阴性患者术后1年运动、认知及生活质量结局无显著差异。
  • 两组术后MDS-UPDRS IV、III(开刺激关状态)及多巴胺能药物剂量均显著下降,组间无差异。
  • 术前RBD阳性患者术前非运动症状及精神行为表现更重,但术后1年结局与阴性患者相当。

核心结论

  • 在适合丘脑底核脑深部电刺激(STN-DBS)的帕金森病患者中,术前很可能RBD的存在与术后1年临床结局无关。

研究设计与样本

  • 法国多中心前瞻性研究PREDISTIM(NCT02360683),分析448例帕金森病患者的术前临床特征,其中215例完成术后12个月随访。
  • 根据RBD单一问题及RBD筛查问卷将患者分为术前很可能RBD阳性组与阴性组,比较术后运动、认知、精神行为及生活质量结局。

主要发现

  • 术前评估时,RBD阳性组年龄更大(61 ± 7.2 vs 59.5 ± 7.7岁;p = 0.02),MDS-UPDRS III关状态评分更低(38.7 ± 16.2 vs 43.4 ± 7.1;p = 0.03)。
  • RBD阳性组MDS-UPDRS I评分更高(12.6 ± 5.5 vs 10.7 ± 5.3;p < 0.001),Ardouin行为量表总分更高(7.7 ± 5.1 vs 5.1 ± 0.4;p = 0.003),PDQ-39评分更差(33 ± 12 vs 29 ± 12;p = 0.03)。
  • 术后两组MDS-UPDRS IV评分分别下降37%和33%,MDS-UPDRS III(药物关/刺激开)评分分别下降52%和54%,多巴胺能药物剂量分别下降52%和49%,组间无差异。
  • 认知及整体生活质量结局组间无差异。

临床怎么用

  • 术前很可能RBD不应作为排除STN-DBS或预测术后1年结局更差的依据。
  • 术前RBD阳性患者非运动症状和精神行为表现更重,术后仍需关注这些方面。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: To determine whether patients with Parkinson disease (PD) eligible for subthalamic nucleus deep brain stimulation (STN-DBS) with probable REM sleep behavior disorder (RBD) preoperatively could be more at risk of poorer motor, nonmotor, and quality of life outcomes 12 months after surgery compared to those without RBD. METHODS: We analyzed the preoperative clinical profile of 448 patients with PD from a French multicentric prospective study (PREDISTIM) according to the presence or absence of probable RBD based on the RBD Single Question and RBD Screening Questionnaire. Among the 215 patients with PD with 12 months of follow-up after STN-DBS, we compared motor, cognitive, psycho-behavioral profile, and quality of life outcomes in patients with (pre-opRBD+) or without (pre-opRBD-) probable RBD preoperatively. RESULTS: At preoperative evaluation, pre-opRBD+ patients were older (61 ± 7.2 vs 59.5 ± 7.7 years; p = 0.02), had less motor impairment (Movement Disorder Society-sponsored version of the Unified Parkinson's Disease Rating Scale [MDS-UPDRS] III "off": 38.7 ± 16.2 vs 43.4 ± 7.1; p = 0.03) but more nonmotor symptoms on daily living activities (MDS-UPDRS I: 12.6 ± 5.5 vs 10.7 ± 5.3; p < 0.001), had more psychobehavioral manifestations (Ardouin Scale of Behavior in Parkinson's Disease total: 7.7 ± 5.1 vs 5.1 ± 0.4; p = 0.003), and had worse quality of life (Parkinson's Disease Questionnaire-39: 33 ± 12 vs 29 ± 12; p = 0.03), as compared to pre-opRBD- patients. Both pre-opRBD+ and pre-opRBD- patients had significant MDS-UPDRS IV score decrease (-37% and -33%, respectively), MDS-UPDRS III "med 'off'/stim 'on'" score decrease (-52% and -54%), and dopaminergic treatment decrease (-52% and -49%) after surgery, with no between-group difference. There was no between-group difference for cognitive and global quality of life outcomes. CONCLUSIONS: In patients with PD eligible for STN-DBS, the presence of probable RBD preoperatively is not associated with a different clinical outcome 1 year after neurosurgery. TRIAL REGISTRATION INFORMATION: NCT02360683. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients with PD eligible for STN-DBS, the presence of probable RBD preoperatively is not associated with poorer outcomes 1 year post surgery.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Besse-Pinot E, Pereira B, Durif F, et al. Preoperative REM Sleep Behavior Disorder and Subthalamic Nucleus Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery. Neurology. 2021. PMID: 34667082. doi:10.1212/WNL.0000000000012862

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。